Professor Ian Collins' Team searches for new molecules that inhibit the activity of proteins responsible for the development and progression of cancer.
Professor Ian Collins leads a medicinal chemistry team at The Institute of Cancer Research and is a key member of the Cancer Research UK Cancer Therapeutics Unit. The team develops molecules which are then used as tools to understand cancer biology and can be developed to make new drugs.